Effect of levosimendan on ventricular remodelling in patients with left ventricular systolic dysfunction: a meta‐analysis

Abstract Heart failure is the final stage of several cardiovascular diseases, and the key to effectively treating heart failure is to reverse or delay ventricular remodelling. Levosimendan is a novel inotropic and vasodilator agent used in heart failure, whereas the impact of levosimendan on ventric...

Full description

Bibliographic Details

Published in:	ESC Heart Failure
Main Authors:	Xia Wang, Xiu‐Zhi Zhao, Xi‐Wen Wang, Lu‐Ying Cao, Bin Lu, Zhi‐Hao Wang, Wei Zhang, Yun Ti, Ming Zhong
Format:	Article
Language:	English
Published:	Wiley 2024-06-01
Subjects:	Levosimendan Left ventricular systolic dysfunction Ventricular remodelling Safety Meta‐analysis
Online Access:	https://doi.org/10.1002/ehf2.14714